Sep 5, 2025 07:30AM
Sep 5, 2025 07:30AM
Jul 9, 2025 07:30AM
Apr 9, 2025 07:30AM
Apr 8, 2025 07:00AM
Apr 8, 2025 07:00AM
Mar 25, 2025 05:50PM Theratechnologies (THTX) announces FDA approval of EGRIFTA WR
Mar 25, 2025 05:45PM
Feb 26, 2025 07:30AM
Feb 13, 2025 07:45PM
Jan 9, 2025 05:05PM
Dec 18, 2024 01:33PM
Dec 18, 2024 01:30PM
Dec 10, 2024 03:15PM Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA
Dec 9, 2024 07:33AM
Dec 9, 2024 07:30AM
Dec 4, 2024 07:30AM
Dec 4, 2024 07:30AM
Dec 3, 2024 04:30PM
Dec 3, 2024 04:30PM
Nov 26, 2024 07:32AM Theratechnologies (THTX) Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review
Nov 26, 2024 07:30AM
Oct 10, 2024 07:30AM
Sep 17, 2024 05:01PM
Sep 17, 2024 05:00PM
Jul 10, 2024 07:30AM
May 23, 2024 05:00PM
May 2, 2024 07:30AM Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
Apr 10, 2024 07:30AM
Apr 8, 2024 04:30PM
Mar 28, 2024 07:30AM
Mar 22, 2024 09:37AM
Mar 22, 2024 09:36AM
Mar 21, 2024 07:31AM
Mar 21, 2024 07:30AM Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
Feb 27, 2024 07:30AM
Feb 27, 2024 07:30AM
Feb 21, 2024 07:30AM
Feb 20, 2024 07:32AM
Feb 20, 2024 07:30AM
Feb 15, 2024 07:30AM
Feb 6, 2024 07:30AM Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
Jan 24, 2024 07:05AM
Jan 24, 2024 07:00AM
Jan 23, 2024 07:33AM
Jan 23, 2024 07:30AM
Jan 2, 2024 07:30AM
Jan 2, 2024 07:30AM
Dec 13, 2023 07:30AM Theratechnologies (THTX) Announces FDA Approval of Trogarzo
Dec 13, 2023 07:30AM

322,243 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All